Evidence map›Paper›PMID 33611507›Full record

ArticleJournal of neuropathology and experimental neurology2021

The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy.

Kevin F Bieniek, Nigel J Cairns, John F Crary, Dennis W Dickson, Rebecca D Folkerth, C Dirk Keene, Irene Litvan, Daniel P Perl, Thor D Stein, Jean-Paul Vonsattel and 9 more

Open access · hybridAbstract readConsensus Development Conference, NIH
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 211 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
211citing papers in PubMed, 3 pooled it
21.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

211 citing papers in PubMed, 3 syntheses or guidelines pooled it, 304 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Comparing perceptions of chronic traumatic encephalopathy (CTE) across health care disciplines.PM & R : the journal of injury, function, and rehabilitation · 2026
    Article
  8. Article
  9. Heterogenous Neuropathology in a Pedigree with RAB39B-Related Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Brain regional susceptibility to tauopathy in individuals at risk for chronic traumatic encephalopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

151 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 2 countries.

Kevin F BieniekDepartment of Pathology, Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, Texas.
Nigel J CairnsDepartment of Neurology, Washington University School of Medicine, Saint Louis, Missouri.
John F CraryDepartments of Pathology & Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Freidman Brain Institute, Icahn School of Medicine at Mount Sinai School, New York, New York.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Rebecca D FolkerthNew York City Office of Chief Medical Examiner and Department of Forensic Medicine, New York University School of Medicine, New York, New York.
C Dirk KeeneDepartment of Pathology, University of Washington School of Medicine, Seattle, Washington.
Irene LitvanDepartment of Neurosciences, University of California San Diego School of Medicine, La Jolla, California.
Daniel P PerlDepartment of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Thor D SteinVA Boston Healthcare System, Boston, Massachusetts.
Jean-Paul VonsattelTaub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York.
William StewartDepartment of Neuropathology, University of Glasgow Institute of Neuroscience and Psychology and Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Kristen Dams-O'ConnorDepartment of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Wayne A GordonDepartment of Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Yorghos TripodisAlzheimer's Disease Center, CTE Program, Boston University School of Medicine, Boston, Massachusetts; Department of Veteran Affairs Medical Center, Bedford, Massachusetts.
Victor E AlvarezVA Boston Healthcare System, Boston, Massachusetts.
Jesse MezDepartment of Neurology, Boston University School of Medicine, Boston, Massachusetts; Department of Veteran Affairs Medical Center, Bedford, Massachusetts.
Michael L AloscoDepartment of Neurology, Boston University School of Medicine, Boston, Massachusetts; Department of Veteran Affairs Medical Center, Bedford, Massachusetts.
Ann C McKeeVA Boston Healthcare System, Boston, Massachusetts.
TBI/CTE Research Group
Boston Medical Center · USIcahn School of Medicine at Mount Sinai · USColumbia University Irving Medical Center · USBedford VA Research Corporation · USBoston University · USInstitute for Neurodegenerative Disorders · USMayo Clinic in Florida · USNew York University · USQueen Elizabeth University Hospital · GBUniformed Services University of the Health Sciences · USUniversity of California, San Diego · USUniversity of Washington · USVA Boston Healthcare System · USWashington University in St. Louis · US

Funding

Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI FAGAN, ANNE · 1985 to 2019
$52.1M
Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
MRI, Genetics &Cognitive Precursors of AD &DementiaR01AG016495 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 1999 to 2016
$12.5M
The Late Effects of TBI (LETBI) Study: Injury Patterns and Biological Markers of Post-Traumatic NeurodegenerationRF1NS115268 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Kristen Dams-O'Connor · 2019 to 2026
$10.3M
Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo DiagnosticsU01NS086625 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN · 2014 to 2017
$6.1M
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo ImagingU01NS086659 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2014 to 2017
$6.1M
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)R01AG061028 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN, MEZ, JESSE BENJAMIN · 2019 to 2023
$5.9M
Neuropathological Characterization of 'CTE'R01NS094003 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI Douglas Hamilton Smith, William Stewart · 2016 to 2026
$5.1M
The Contribution of Age-Related Taupahtoies to Alzheimer's Disease-SupplementR01AG062348 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CRARY, JOHN FONDA, DICKSON, DENNIS WILLIAM · 2018 to 2022
$4.5M
Tau Pathology in CTE vs. Alzheimer's Disease: Microvasculopathy and NeuroinflammationRF1AG057902 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MCKEE, ANN C. · 2017 to 2017
$4.1M
Mechanisms of Age-Related TauopathyR01NS095252 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI John Fonda Crary · 2015 to 2026
$3.4M
NIA NIH HHS P01 AG003991NIA NIH HHS P30 AG013846NIA NIH HHS P50 AG005681NIA NIH HHS R01 AG016495NIA NIH HHS R01 AG061028NIA NIH HHS R01 AG062348NIA NIH HHS RF1 AG057902NINDS NIH HHS R01 NS078337NINDS NIH HHS R01 NS094003NINDS NIH HHS R01 NS095252NINDS NIH HHS R56 NS078337NINDS NIH HHS RF1 NS095252NINDS NIH HHS RF1 NS115268NINDS NIH HHS U01 NS086625NINDS NIH HHS U01 NS086659
6 · The paper itself

Abstract

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder associated with exposure to head trauma. In 2015, a panel of neuropathologists funded by the NINDS/NIBIB defined preliminary consensus neuropathological criteria for CTE, including the pathognomonic lesion of CTE as "an accumulation of abnormal hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood vessels at the depths of cortical sulci and in an irregular pattern," based on review of 25 tauopathy cases. In 2016, the consensus panel met again to review and refine the preliminary criteria, with consideration around the minimum threshold for diagnosis and the reproducibility of a proposed pathological staging scheme. Eight neuropathologists evaluated 27 cases of tauopathies (17 CTE cases), blinded to clinical and demographic information. Generalized estimating equation analyses showed a statistically significant association between the raters and CTE diagnosis for both the blinded (OR = 72.11, 95% CI = 19.5-267.0) and unblinded rounds (OR = 256.91, 95% CI = 63.6-1558.6). Based on the challenges in assigning CTE stage, the panel proposed a working protocol including a minimum threshold for CTE diagnosis and an algorithm for the assessment of CTE severity as "Low CTE" or "High CTE" for use in future clinical, pathological, and molecular studies.

Indexed as

AdultAgedAged, 80 and overChronic Traumatic EncephalopathyFemaleHumansMaleMiddle AgedNational Institute of Biomedical Imaging and Bioengineering (U.S.)National Institute of Neurological Disorders and Stroke (U.S.)NeuropathologySingle-Blind MethodUnited StatesYoung AdultBrain traumaChronic traumatic encephalopathyNeurodegenerative disordersTauopathyTraumatic brain injury

Identifiers

PMID33611507
PMCPMC7899277
OpenAlexW3131153821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.